Professional societies recommend continuing ACE inhibitors and ARBs in patients with COVID-19. Trials testing whether they might actually be of benefit have ramped up and begun recruiting.
from WebMD Health https://www.webmd.com/lung/news/20200406/stay-on-angiotensin-drugs-still-the-message-as-trials-begin?src=RSS_PUBLIC
0 Comments:
Post a Comment